15,385 reports of this reaction
2.2% of all LEFLUNOMIDE reports
#7 most reported adverse reaction
FATIGUE is the #7 most commonly reported adverse reaction for LEFLUNOMIDE, manufactured by sanofi-aventis U.S. LLC. There are 15,385 FDA adverse event reports linking LEFLUNOMIDE to FATIGUE. This represents approximately 2.2% of all 696,911 adverse event reports for this drug.
Patients taking LEFLUNOMIDE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for LEFLUNOMIDE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for LEFLUNOMIDE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 15,385 FDA reports for LEFLUNOMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.2% of all adverse event reports for LEFLUNOMIDE, making it a notable side effect.
If you experience fatigue while taking LEFLUNOMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.